Avadel Pharmaceuticals
AVDL
AVDL was delisted on the 11th of February, 2026.
56 hedge funds and large institutions have $211M invested in Avadel Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 8 closing their positions.
717% more call options, than puts
Call options by funds: $29.6M | Put options by funds: $3.62M
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
52% more capital invested
Capital invested by funds: $139M → $211M (+$72.5M)
33% more funds holding
Funds holding: 42 → 56 (+14)
22.5% more ownership
Funds ownership: 49.08% → 71.59% (+23%)
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$33.5M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$27.5M |
| 3 |
CAC
Cowen and Company
New York
|
+$11.7M |
| 4 |
RI
RTW Investments
New York
|
+$9.33M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$8.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$15.5M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$13.8M |
| 3 |
GJL
Gendell Jeffrey L
|
-$4.56M |
| 4 |
Morgan Stanley
New York
|
-$4.33M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.26M |
AVDL Hedge Fund Activity: Q1 2020 in Review
56 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2020, worth a combined $211M — up 52% from $139M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new AVDL positions and 8 closed out — a net gain of 17 holders — while 7 added to existing stakes and 15 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $33.5M. The largest seller was Brandes Investment Partners, cutting an estimated $15.5M.
- 56 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2020, up from 42 in Q4 2019.
- Funds reported $211M of Avadel Pharmaceuticals stock for Q1 2020, up 52% quarter-over-quarter.
- 25 funds opened new Avadel Pharmaceuticals positions in Q1 2020 and 8 closed out, a net change of +17 holders.
- The largest Avadel Pharmaceuticals buyer in Q1 2020 was Avoro Capital Advisors, an estimated $33.5M added.
- The largest Avadel Pharmaceuticals seller in Q1 2020 was Brandes Investment Partners, an estimated $15.5M sold.
Based on aggregated 13F filings for Q1 2020.